Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study

European Urology

Volumn 49, Issue 4, 2006, Pages 704-709

  Giannantoni, Antonella ^a   Costantini, Elisabetta ^a   Di Stasi, Savino M ^b   Tascini, Maria Cristina ^a   Bini, Vittorio ^a   Porena, Massimo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Bladder; Botulinum toxin A; Painful bladder syndrome

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; BLADDER DYSFUNCTION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; MALE; MICTURITION; PRIORITY JOURNAL; URINARY FREQUENCY; URODYNAMICS; VISUAL ANALOG SCALE;

ADMINISTRATION, INTRAVESICAL; AGED; BOTULINUM TOXIN TYPE A; CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN MEASUREMENT; PILOT PROJECTS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33644860325     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.12.002     Document Type: Article

References (26)

1. M.B. Chancellor, and N. Yoshimura Treatment of interstitial cystitis Urology 63 suppl 3A 2004 85 92
2. A.C. Diokno, Y. Homma, Y. Sekiguchi, and Y. Suzuki Interstitial cystitis, gynaecologic pelvic pain, prostatitis, and their epidemiology Int J Urol 10 2003 S3 S6
3. R. Popat, A. Apostolidis, V. Kalsi, G. Gonzales, C.J. Fowler, and P. Dasgupta A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum A toxin J Urol 174 2005 984 989
4. A. Reitz, M. Stohrer, G. Kramer, G. Del Popolo, E. Chartier-Kastler, and J. Pannek European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity Eur Urol 45 2004 510 515
5. A. Haferkamp, B. Schurch, A. Reitz, U. Krengel, J. Grosse, and G. Kramer Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder Eur Urol 46 2004 784 791
6. S. Cayan, B. Coskun, M. Bozlu, D. Acar, E. Akbay, and E. Ulusoy Botulinum toxin type A may improve bladder function in a rat chemical cystitis model Urol Res 30 2003 399 404
7. C.P. Smith, and M.B. Chancellor Emerging role of botulinum toxin in the management of voiding dysfunction J Urol 171 2004 2128 2137
8. M.J. Duggan, C.P. Quinn, J.A. Chaddock, J.R. Purkiss, Alexander FCG, and S. Doward Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a clostridium botulinum toxin A endopeptidase fragment and erythrina cristagalli lectin J Biol Chem 277 2002 34846 34852
9. P. Abrams, L. Cardozo, M. Fall, D. Griffiths, P. Rosier, and U. Ulmsten The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167
10. J.K. Tsui, A. Eisen, and A.J. Stoessl Double-blind study of botulinum toxin in spasmodic torticollis Lancet 2 1986 245 247
11. W.P. Cheshire, S.W. Abashian, and J.D. Mann Botulinum toxin in the treatment of myofascial pain syndrome Pain 59 1994 65 69
12. B. Silberstein, N. Maher, and M.P. Difasio Botulinum toxin type A as a migraine preventive treatment Headache 40 2000 445 450
13. M.J. Welch, J.R. Purkiss, and K.A. Foster Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins Toxicon 38 2000 245 248
14. B. Jabbari, N. Maher, and M.P. Difazio Botulinum toxin-A improved burning pain and allodynia in two patients with spinal cord pathology Pain Med 4 2003 206 208
15. D.H. Zermann, M. Ishigooka, and J. Schubert Trigonum and bladder base injection of severe urgency-frequency syndrome refractory to conservative medical treatment and electrical stimulation Neurourol Urodyn 20 2001 412 413
16. C.P. Smith, P. Radziszewski, A. Borkowski, G.T. Somogyi, T.B. Boone, and M.B. Chancellor Botulinum toxin A has antinociceptive effects in treating interstitial cystitis Urology 64 2004 871 875
17. Maggi CA. The dual sensory and efferent functions of the capasaicin-sensitive primary sensory nerves in the bladder and urethra. In: Maggi, C.A., editor. The Autonomic Nervous System: Nervous Control of the Urogenital System, vol. 3. London, Harwood Academic Publisher, London, p. 383.
18. M. Khera, G.T. Somogyi, S. Kiss, T.B. Boone, and C.P. Smith Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury Neurochem Int 45 2004 987 993
19. Y. Sun, S. Keay, P.G. De Deyne, and T.C. Chai Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis J Urol 166 2001 1951 1956
20. A. Giannantoni, S.M. Di Stasi, V. Nardicchi, L. Macchioni, F. Guercini, and G. Goracci Botulinum A toxin intravesical treatment induces a reduction of nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity J Urol 173 2005 330
21. Q.T. Dinh, D.A. Groneberg, C. Peisert, J. Springer, R.A. Joachim, and P.C. Arck Nerve growth factor-induced substance P in capsaicin insensitive vagal neurons innervating the lower mouse airway Clin Exp Allergy 34 2004 1474 1479
22. K.E. Andersson, and M. Yoshida Antimuscarinics and the overactive detrusor-which is the main mechanism of action Eur Urol 43 2003 1 5
23. J.H. Ku, S.W. Kim, and J.S. Paick Quality of life and psychological factors in chronic prostatitis/chronic pelvic pain syndrome Urology 66 2005 693
24. R.M. Moldwin, and G.R. Sant Interstitial cystitis: a pathophysiology and treatment update Clin Obstet Gynecol 45 2002 259
25. C.P. Smith, P. Radziszewski, A. Borkowski, G.T. Somogyi, T.B. Boone, and M.B. Chancellor Botulinum toxin a has antinociceptive effects in treating interstitial cystitis Urology 64 2004 871
26. H.C. Kuo Preliminary results of suburothelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis Urol Int 75 2005 170